Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

NCT01720602 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Male Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: vorinostat
DRUG: anastrozole
DRUG: letrozole
DRUG: exemestane
PROCEDURE: positron emission tomography
RADIATION: F-18 16 alpha-fluoroestradiol
RADIATION: fludeoxyglucose F 18
OTHER: laboratory biomarker analysis

Sponsor

University of Washington

Collaborators

[object Object]